tiprankstipranks
Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
US Market
Holding VPHIF?
Track your performance easily

Valeo Pharma (VPHIF) Financial Statements

14 Followers

Valeo Pharma Financial Overview

Valeo Pharma's market cap is currently ―. The company's EPS TTM is $-0.25; its P/E ratio is ―; Valeo Pharma is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue$ 12.60M$ 14.13M$ 13.54M$ 13.11M$ 14.08M
Gross Profit$ 3.04M$ 3.38M$ 2.75M$ 632.00K$ 3.67M
EBIT$ -3.29M$ -3.11M$ -3.20M$ -5.69M$ -4.64M
EBITDA$ -2.66M$ -2.48M$ -2.54M$ -4.94M$ -4.01M
Net Income Common Stockholders$ -8.19M$ -7.81M$ -6.87M$ -9.45M$ -7.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.13M$ 6.89M$ 9.59M$ 7.50M$ 9.78M
Total Assets$ 32.20M$ 34.57M$ 40.35M$ 41.21M$ 45.54M
Total Debt$ 46.04M$ 44.12M$ 42.87M$ 65.17M$ 62.79M
Net Debt$ 38.91M$ 37.23M$ 33.28M$ 57.67M$ 53.02M
Total Liabilities$ 95.23M$ 89.44M$ 87.37M$ 81.54M$ 80.58M
Stockholders Equity$ -63.03M$ -54.87M$ -47.01M$ -40.34M$ -35.05M
Cash Flow-
Free Cash Flow$ 451.00K$ -2.03M$ 1.86M$ -7.70M$ -1.66M
Operating Cash Flow$ 451.00K$ -3.31M$ 1.63M$ -2.67M$ -1.55M
Investing Cash Flow-$ 1.29M$ 225.00K$ -5.03M$ -111.00K
Financing Cash Flow$ -248.00K$ -840.00K$ 460.00K$ 5.05M$ 1.53M
Currency in USD

Valeo Pharma Earnings and Revenue History

Valeo Pharma Debt to Assets

Valeo Pharma Cash Flow

Valeo Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis